REVIEW Chromatin Immunoprecipitation: Advancing
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
DNA Footprinting with an Automated DNA Analyzer: Does the Shoe Fit?
DNA Footprinting with an automated DNA Analyzer: does the shoe fit? Michael Zianni Manager, Plant-Microbe Genomics Facility DNA Footprinting with an Applied Biosystems 3730 DNA Analyzer: does the shoe fit ……….yes! DNA Footprint Analysis DNA Fragment BSA 6FAM DNA Binding Protein 6FAM Endonuclease Digestion (DNase I) 6FAM 6FAM 6FAM 6FAM 6FAM 6FAM 6FAM Capillary Electrophoresis rfu rfu Size (bp) Size (bp) 6FAM HrpY DNA Fragment 6FAM BSA 6FAM HrpY DNA Fragment 6FAM BSA Endonuclease EndonucleaseDigestion (DNaseDigestion I) (DNase I) 6FAM 6FAM 6FAM 6FAM 6FAM 6FAM 6FAM 6FAM 6FAM 6FAM 6FAM 6FAM 6FAM 6FAM Capillary ElectrophoresisCapillary Electrophoresis rfu rfu rfu rfu Size (bp) Size (bp) Size (bp) Size (bp) Development of DNA Foot print Analysis Techniques and Goals of This Study First performed in 1977, and utilized radioactively labeled DNA, slab gels, and autoradiography In 1994, dyes and fluorescent gel imager were used instead of radioisotopes and autoradiography but the slab gel remained. In 2000, the slab gel and imager were replaced by an automated capillary electrophoresis instrument: 310 DNA Analyzer. In 2004, ........... Demonstrate the feasibility by reproducing a protection assay previously done with autoradiography and a slab gel Demonstrate that each peak could be accurately identified Apply this method to a previously uncharacterized protein DNA Footprint analysis with protein: Autoradiography vs Electropherogram DNA Footprint analysis without protein: Electropherogram vs Autoradiography Fluorescent Primer Design For use in: (1) the DNA sequencing reactions which act as a standard/ladder and (2) the PCR reaction to make the DNA probe Used routine DNA sequencing guidelines: 18 -25mer. Tm at 55 – 60C. about 50% GC. -
Analysis of Proteins by Immunoprecipitation
Laboratory Procedures, PJ Hansen Laboratory - University of Florida Analysis of Proteins by Immunoprecipitation P.J. Hansen1 1Dept. of Animal Sciences, University of Florida Introduction Immunoprecipitation is a procedure by which peptides or proteins that react specifically with an antibody are removed from solution and examined for quantity or physical characteristics (molecular weight, isoelectric point, etc.). As usually practiced, the name of the procedure is a misnomer since removal of the antigen from solution does not depend upon the formation of an insoluble antibody-antigen complex. Rather, antibody-antigen complexes are removed from solution by addition of an insoluble form of an antibody binding protein such as Protein A, Protein G or second antibody (Figure 1). Thus, unlike other techniques based on immunoprecipitation, it is not necessary to determine the optimal antibody dilution that favors spontaneously-occurring immunoprecipitates. Figure 1. Schematic representation of the principle of immunoprecipitation. An antibody added to a mixture of radiolabeled (*) and unlabeled proteins binds specifically to its antigen (A) (left tube). Antibody- antigen complex is absorbed from solution through the addition of an immobilized antibody binding protein such as Protein A-Sepharose beads (middle panel). Upon centrifugation, the antibody-antigen complex is brought down in the pellet (right panel). Subsequent liberation of the antigen can be achieved by boiling the sample in the presence of SDS. Typically, the antigen is made radioactive before the immunoprecipitation procedure, either by culturing cells with radioactive precursor or by labeling the molecule after synthesis has been completed (e.g., by radioiodination to iodinate tyrosine residues or by sodium [3H]borohydride reduction to label carbohydrate). -
Locating Mammalian Transcription Factor Binding Sites: a Survey of Computational and Experimental Techniques
Downloaded from genome.cshlp.org on September 26, 2021 - Published by Cold Spring Harbor Laboratory Press Review Locating mammalian transcription factor binding sites: A survey of computational and experimental techniques Laura Elnitski,1,4 Victor X. Jin,2 Peggy J. Farnham,2 and Steven J.M. Jones3 1Genomic Functional Analysis Section, National Human Genome Research Institute, National Institutes of Health, Rockville, Maryland 20878, USA; 2Genome and Biomedical Sciences Facility, University of California–Davis, Davis, California 95616-8645, USA; 3Genome Sciences Centre, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada V5Z-4E6 Fields such as genomics and systems biology are built on the synergism between computational and experimental techniques. This type of synergism is especially important in accomplishing goals like identifying all functional transcription factor binding sites in vertebrate genomes. Precise detection of these elements is a prerequisite to deciphering the complex regulatory networks that direct tissue specific and lineage specific patterns of gene expression. This review summarizes approaches for in silico, in vitro, and in vivo identification of transcription factor binding sites. A variety of techniques useful for localized- and high-throughput analyses are discussed here, with emphasis on aspects of data generation and verification. [Supplemental material is available online at www.genome.org.] One documented goal of the National Human Genome Research and other regulatory elements is mediated by DNA/protein in- Institute (NHGRI) is the identification of all functional noncod- teractions. Thus, one major step in the characterization of the ing elements in the human genome (ENCODE Project Consor- functional elements of the human genome is the identification tium 2004). -
The Immunoassay Guide to Successful Mass Spectrometry
The Immunoassay Guide to Successful Mass Spectrometry Orr Sharpe Robinson Lab SUMS User Meeting October 29, 2013 What is it ? Hey! Look at that! Something is reacting in here! I just wish I knew what it is! anti-phospho-Tyrosine Maybe we should mass spec it! Coffey GP et.al. 2009 JCS 22(3137-44) True or false 1. A big western blot band means I have a LOT of protein 2. One band = 1 protein Big band on Western blot Bands are affected mainly by: Antibody affinity to the antigen Number of available epitopes Remember: After the Ag-Ab interaction, you are amplifying the signal by using an enzyme linked to a secondary antibody. How many proteins are in a band? Human genome: 20,000 genes=100,000 proteins There are about 5000 different proteins, not including PTMs, in a given cell at a single time point. Huge dynamic range 2D-PAGE: about 1000 spots are visible. 1D-PAGE: about 60 -100 bands are visible - So, how many proteins are in my band? Separation is the key! Can you IP your protein of interest? Can you find other way to help with the separation? -Organelle enrichment -PTMs enrichment -Size enrichment Have you optimized your running conditions? Choose the right gel and the right running conditions! Immunoprecipitation, in theory Step 1: Create a complex between a desired protein (Antigen) and an Antibody Step 2: Pull down the complex and remove the unbound proteins Step 3: Elute your antigen and analyze Immunoprecipitation, in real life Flow through Wash Elution M 170kDa 130kDa 100kDa 70kDa 55kDa 40kDa 35kDa 25kDa Lung tissue lysate, IP with patient sera , Coomassie stain Rabinovitch and Robinson labs, unpublished data Optimizing immunoprecipitation You need: A good antibody that can IP The right beads: i. -
Wo2015188839a2
Downloaded from orbit.dtu.dk on: Oct 08, 2021 General detection and isolation of specific cells by binding of labeled molecules Pedersen, Henrik; Jakobsen, Søren; Hadrup, Sine Reker; Bentzen, Amalie Kai; Johansen, Kristoffer Haurum Publication date: 2015 Document Version Publisher's PDF, also known as Version of record Link back to DTU Orbit Citation (APA): Pedersen, H., Jakobsen, S., Hadrup, S. R., Bentzen, A. K., & Johansen, K. H. (2015). General detection and isolation of specific cells by binding of labeled molecules. (Patent No. WO2015188839). General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. Users may download and print one copy of any publication from the public portal for the purpose of private study or research. You may not further distribute the material or use it for any profit-making activity or commercial gain You may freely distribute the URL identifying the publication in the public portal If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2015/188839 -
What Would You Do If You Could Sequence Everything?
PERspECTIVE What would you do if you could sequence everything? Avak Kahvejian1, John Quackenbush2 & John F Thompson1 It could be argued that the greatest transformative aspect ing technologies, be leveraged with insightful approaches to biology and of the Human Genome Project has been not the sequencing medicine to maximize the benefits to all? DNA sequence is no longer just of the genome itself, but the resultant development of new an end in itself, but it is rapidly becoming the digital substrate replac- technologies. A host of new approaches has fundamentally ing analog chip-based hybridization signals; it is the barcode tracking of changed the way we approach problems in basic and enormous numbers of samples; and it is the readout indicating a host of translational research. Now, a new generation of high-throughput chemical modifications and intermolecular interactions. Sequence data sequencing technologies promises to again transform the allow one to count mRNAs or other species of nucleic acids precisely, to scientific enterprise, potentially supplanting array-based determine sharp boundaries for interactions with proteins or positions technologies and opening up many new possibilities. By allowing of translocations and to identify novel variants and splice sites, all in one http://www.nature.com/naturebiotechnology DNA/RNA to be assayed more rapidly than previously possible, experiment with digital accuracy. these next-generation platforms promise a deeper understanding The brief history of molecular biology and genomic technologies has of genome regulation and biology. Significantly enhancing been marked by the introduction of new technologies, their rapid uptake sequencing throughput will allow us to follow the evolution and then a steady state or slow decline in use as newer techniques are of viral and bacterial resistance in real time, to uncover the developed that supersede them. -
FACT Is Recruited to the +1 Nucleosome of Transcribed Genes and Spreads in a Chd1-Dependent Manner
bioRxiv preprint doi: https://doi.org/10.1101/2020.08.20.259960; this version posted August 21, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. FACT is recruited to the +1 nucleosome of transcribed genes and spreads in a Chd1-dependent manner Célia Jeronimo1, Andrew Angel2, Christian Poitras1, Pierre Collin1, Jane Mellor2 and François Robert1,3,4* 1 Institut de recherches cliniques de Montréal, 110 Avenue des Pins Ouest, Montréal, QC H2W 1R7, Canada. 2Department of Biochemistry, University of Oxford, South Parks Road, Oxford, OX1 3QU, UK. 3 Département de Médecine, Faculté de Médecine, Université de Montréal, 2900 Boul. Édouard- Montpetit, Montréal, QC H3T 1J4, Canada. 4 Lead Contact *Correspondence: [email protected] The histone chaperone FACT occupies transcribed regions where it plays prominent roles in maintaining chromatin integrity and preserving epigenetic information. How it is targeted to transcribed regions, however, remains unclear. Proposed models for how FACT finds its way to transcriptionally active chromatin include docking on the RNA polymerase II (RNAPII) C-terminal domain (CTD), recruitment by elongation factors, recognition of modified histone tails and binding partially disassembled nucleosomes. Here, we systematically tested these and other scenarios in Saccharomyces cerevisiae and found that FACT binds transcribed chromatin, not RNAPII. Through a combination of experimental and mathematical modeling evidence, we propose that FACT recognizes the +1 nucleosome, as it is partially unwrapped by the engaging RNAPII, and spreads to downstream nucleosomes aided by the chromatin remodeler Chd1. -
Anti-GFP (Green Fluorescent Protein) Mab-Agarose Code No
D153-8 For Research Use Only. Page 1 of 2 Not for use in diagnostic procedures. MONOCLONAL ANTIBODY Anti-GFP (Green Fluorescent Protein) mAb-Agarose Code No. Clone Subclass Quantity D153-8 RQ2 Rat IgG2a Gel: 200 L BACKGROUND: Since the detection of intracellular 5) Dragone, L. L., et al., PNAS. 103, 18202-18207 (2006) [IP] Aequorea Victria Green Fluorescent Protein (GFP) requires 6) Darzacq, X., et al., J. Cell Biol. 173, 207-218 (2006) [ChIP] only irradiation by UV or blue light, it provides an excellent 7) Hayakawa, T., et al., Plant Cell Physiol. 47, 891-904 (2006) [IP] means for monitoring gene expression and protein 8) Obuse, C., et al., Nat. Cell Biol. 6, 1135-1141 (2004) [IP] localization in living cells. Agarose conjugated anti-GFP monoclonal antibody can detect GFP fusion protein on As this antibody is really famous all over the world, a lot of Immunoprecipitation. researches have been reported. These references are a part of such reports. SOURCE: This antibody was purified from hybridoma (clone RQ2) supernatant using protein G agarose. This INTENDED USE: hybridoma was established by fusion of mouse myeloma For Research Use Only. Not for use in diagnostic procedures. cell PAI with Wister rat lymphnode immunized with GFP purified from GFP expressed 293T cells by affinity 1 2 chromatographic technique using mouse anti-GFP. kDa 66 FORMULATION: 100 g of anti-GFP monoclonal antibody covalently coupled to 200 L of agarose gel and 45 provided as a 50% gel slurry suspended in PBS containing GFP fusion protein preservative (0.1% ProClin 150) for a total volume of 400 30 L. -
M.Sc. [Botany] 346 13
cover page as mentioned below: below: mentioned Youas arepage instructedcover the to updateupdate to the coverinstructed pageare asYou mentioned below: Increase the font size of the Course Name. Name. 1. IncreaseCourse the theof fontsize sizefont ofthe the CourseIncrease 1. Name. use the following as a header in the Cover Page. Page. Cover 2. the usein the followingheader a as as a headerfollowing the inuse the 2. Cover Page. ALAGAPPAUNIVERSITY UNIVERSITYALAGAPPA [Accredited with ’A+’ Grade by NAAC (CGPA:3.64) in the Third Cycle Cycle Third the in (CGPA:3.64) [AccreditedNAAC by withGrade ’A+’’A+’ Gradewith by NAAC[Accredited (CGPA:3.64) in the Third Cycle and Graded as Category–I University by MHRD-UGC] MHRD-UGC] by University and Category–I Graded as as Graded Category–I and University by MHRD-UGC] M.Sc. [Botany] 003 630 – KARAIKUDIKARAIKUDI – 630 003 346 13 EDUCATION DIRECTORATEDISTANCE OF OF DISTANCEDIRECTORATE EDUCATION BIOLOGICAL TECHNIQUES IN BOTANY I - Semester BOTANY IN TECHNIQUES BIOLOGICAL M.Sc. [Botany] 346 13 cover page as mentioned below: below: mentioned Youas arepage instructedcover the to updateupdate to the coverinstructed pageare asYou mentioned below: Increase the font size of the Course Name. Name. 1. IncreaseCourse the theof fontsize sizefont ofthe the CourseIncrease 1. Name. use the following as a header in the Cover Page. Page. Cover 2. the usein the followingheader a as as a headerfollowing the inuse the 2. Cover Page. ALAGAPPAUNIVERSITY UNIVERSITYALAGAPPA [Accredited with ’A+’ Grade by NAAC (CGPA:3.64) in the Third Cycle Cycle Third the in (CGPA:3.64) [AccreditedNAAC by withGrade ’A+’’A+’ Gradewith by NAAC[Accredited (CGPA:3.64) in the Third Cycle and Graded as Category–I University by MHRD-UGC] MHRD-UGC] by University and Category–I Graded as as Graded Category–I and University by MHRD-UGC] M.Sc. -
Hiper® Immunoprecipitation Teaching Kit Is Stable for 12 Months from the Date of Manufacture Without Showing Any Reduction in Performance
U n z i p p i n g G e n e s P r o d u c t I n f o r m a t i o n ® HiPer Immunoprecipitation Teaching Kit Product Code: HTI016 Number of experiments that can be performed: 5 Duration of Experiment Storage Instructions The kit is stable for 12 months from the date of manufacture Store 5X Sample Loading Buffer and Protein Marker at -20oC Store 30% Acrylamide-Bisacrylamide Solution, 2.5X Tris SDS Buffer (pH 8.8), 5X Tris SDS Buffer (pH 6.8), 5X Tris-Glycine-SDS Gel Running Buffer, TEMED, Antigen, Antibody and Protein A Sepharose Beads at 2-8oC Other kit contents can be stored at room temperature (15-25oC) 1 Registered Office : Commercial Office 23, Vadhani Industrial Estate,LBS Marg, A-516, Swastik Disha Business Park, Tel: 00-91-22-6147 1919 15 WHO Mumbai - 400 086, India. Via Vadhani Indl. Est., LBS Marg, Fax: 6147 1920, 2500 5764 GMP Tel. : (022) 4017 9797 / 2500 1607 Mumbai - 400 086, India Email : [email protected] CERTIFIED Fax : (022) 2500 2286 Web : www.himedialabs.com The information contained herein is believed to be accurate and complete. However no warranty or guarantee whatsoever is made or is to be implied with respect to such information or with respect to any product, method or apparatus referred to herein Index Sr. No. Contents Page No. 1 Aim 3 2 Introduction 3 3 Principle 3 4 Kit Contents 4 5 Materials Required But Not Provided 4 6 Storage 4 7 Important Instructions 5 8 Procedure 5 9 Flowchart 6 10 Observation and Result 7 11 Interpretation 7 12 Troubleshooting Guide 8 12 SDS-PAGE 8 2 Aim: To learn the technique of immunoprecipitation which involves the precipitation of the antigen-antibody complex by Protein A beads Introduction: Immunoprecipitation (IP) is a widely used procedure in immunology where a protein or antigen is precipitated out of a solution using an antibody that specifically binds to that antigen. -
Nano-Traps for Superior Immunoprecipitation
R Nano-Traps for superior immunoprecipitation ChromoTek GFP-Trap® : Ready-to-use beads for fast and efficient immunoprecipitation chromotek.com | ptglab.com About Us Since its inauguration in 2008, ChromoTek, from its ChromoTek has been part of Proteintech Group base in Martinsried near Munich, Germany, has since 2020. To learn more about ChromoTek, please pioneered the development and commercialization visit www.chromotek.com. of Nanobody-based research reagents. The premium Nanobody-based tools provide a higher level of Proteintech Group, founded in 2002 and headquartered performance than conventional IgG antibodies. in Rosemont, IL, is a leading manufacturer of Proteintech ChromoTek is the global market and product leader antibodies and ELISAs plus HumanKine cytokines and in high-quality and reliable Nanobody-based reagents, growth factors. The Proteintech Group has the largest which assist our customers’ research. In addition, proprietary portfolio of self-manufactured antibodies ChromoTek is a trusted service provider of custom- covering more than 2/3 of the human proteome. With made Nanobodies for the pharmaceutical industry. over 100,000 publications and confirmed specificity, Proteintech Group offers antibodies and immunoassays ChromoTek’s mission is to support extraordinary across research areas. In addition, Proteintech produces discoveries with high-performing Nanobody-based HumanKine cytokines, growth factors, and other proteins affinity reagents in proteomics and cell biology. that are human cell line expressed, highly bioactive, and ChromoTek strives to improve, accelerate, and GMP-grade. It is ISO13485 and ISO9001-2015 accredited. simplify our customers research around the world. To learn more about Proteintech, please visit www.ptglab.com. Cover: Immunoprecipitation of GFP-fusion proteins new tools for better research chromotek.com | ptglab.com R Nano-Traps for superior immunoprecipitation ChromoTek GFP-Trap® : Ready-to-use beads for fast and efficient immunoprecipitation Introduction The GFP-Trap belongs to ChromoTek’s Nano-Trap coupled to beads. -
DNA Affinity Labeling of Adenovirus Type 2 Upstream Promoter Sequence-Binding Factors Identifies Two Distinct Proteins BRIAN SAFER,* ROGER B
MOLECULAR AND CELLULAR BIOLOGY, Jan. 1988, p. 105-113 Vol. 8, No. 1 0270-7306/88/010105-09$02.00/0 Copyright © 1988, American Society for Microbiology DNA Affinity Labeling of Adenovirus Type 2 Upstream Promoter Sequence-Binding Factors Identifies Two Distinct Proteins BRIAN SAFER,* ROGER B. COHEN, SUSAN GARFINKEL, AND JOHN A. THOMPSON Section on RNA and Protein Biosynthesis, Laboratory of Molecular Hematology, National Heart, Lung, and Blood Institute, Bethesda, Maryland 20892 Received 14 July 1987/Accepted 14 October 1987 A rapid affinity labeling procedure with enhanced specificity was developed to identify DNA-binding proteins. 32p was first introduced at unique phosphodiester bonds within the DNA recognition sequence. UV light-dependent cross-linking of pyrimidines to amino acid residues in direct contact at the binding site, followed by micrococcal nuclease digestion, resulted in the transfer of 32p to only those specific protein(s) which recognized the binding sequence. This method was applied to the detection and characterization of proteins that bound to the upstream promoter sequence (-50 to -66) of the human adenovirus type 2 major late promoter. We detected two distinct proteins with molecular weights of 45,000 and 116,000 that interacted with this promoter element. The two proteins differed significantly in their chromatographic and cross-linking behaviors. The accurate and regulated expression of genes tran- sequence (UPS) of the adenovirus type 2 (Ad2) major late scribed by RNA polymerase II requires the interaction of promoter (MLP). Results of deletion and mutation analyses specific DNA-binding proteins with cis-acting promoter ele- have shown that efficient transcription of the Ad2 MLP is ments (2, 10, 14, 29, 36).